Search results
Showing 1876 to 1890 of 8883 results
Awaiting development Reference number: GID-TA11487 Expected publication date: 27 May 2027
Trastuzumab deruxtecan for neoadjuvant treatment of HER2-positive early breast cancer [ID6620]
Awaiting development Reference number: GID-TA11403 Expected publication date: 27 May 2027
Awaiting development Reference number: GID-TA11773 Expected publication date: 27 May 2027
In development Reference number: GID-TA11765 Expected publication date: 24 March 2027
Percutaneous transluminal renal sympathetic denervation for resistant hypertension
Awaiting development Reference number: GID-HTG10527 Expected publication date: TBC
Obinutuzumab for treating serologically active extra-renal lupus [ID6670]
In development Reference number: GID-TA11886 Expected publication date: TBC
Advanced breast cancer: diagnosis and management (Partial update)
In development Reference number: GID-NG10430 Expected publication date: 29 May 2026
In development Reference number: GID-TA10046 Expected publication date: 22 November 2017
Artificial intelligence (AI)-derived software to help clinical decision making in stroke
Awaiting development Reference number: GID-HTG10529 Expected publication date: TBC
Awaiting development Reference number: GID-TA11626 Expected publication date: TBC
In development Reference number: GID-TA11863 Expected publication date: TBC
In development Reference number: GID-QS10196 Expected publication date: 28 January 2027
We are listening to your views on this Technology appraisal guidance. Comments close 14 April 2026.
We are listening to your views on this Technology appraisal guidance. Comments close 7 April 2026.
In development Reference number: GID-TA11516 Expected publication date: 06 May 2027